Ursula Theuretzbacher

Ursula Theuretzbacher founded the Center of Anti-Infective Agents, Vienna, Austria in 1988. She is an independent expert for antibacterial drug Research and Development (R&D) strategies and policies based on clinical and public health needs. Her broad therapeutic area of expertise includes predicting medical needs and market potential, designing target product profiles, early integration of pharmacokinetic/pharmacodynamic concepts, optimisation of dosing and usage approaches, and public funding strategies for antibacterial R&D and initiatives to recover the global pipelines. Previously, she was work package leader or partner in several EU funded international collaborative projects focused on antibacterial drug R&D and reviving of old antibiotics. Additionally, she served as President of the International Society for Anti-Infective Pharmacology, Founding President of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) PK/PD of Anti-Infectives Study Group, and as Executive Committee member of the International Society for Infectious Diseases (ISID). U. Theuretzbacher was member of the coordinating group of the WHO project Priority Pathogen List for R&D and is leading scientist for the Clinical and Preclinical Pipeline analysis, and development of Target Product Profiles at WHO. She is member of scientific advisory groups of national and international funding organisations such as REPAIR Impact Fund and CARB-X. She holds a PhD in Microbiology from the University of Vienna and the University of Innsbruck in Austria and lectured at the University of Vienna for 10 years.